Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	16507	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	18013	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	19347	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	19479	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	21022	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	24060	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	24368	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	25263	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	25688	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	26806	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	27243	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	27278	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	27297	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	27401	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	28129	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	28932	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	30653	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	31902	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	32228	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	32238	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	32707	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	33277	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	33548	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	34196	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	34894	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	34905	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	36008	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	36441	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	36788	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	36996	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	38043	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	38377	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	38381	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	38801	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	39065	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	39419	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	40483	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	40794	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	40807	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	41141	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	41302	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	41321	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	41340	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	42371	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	42689	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	42904	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	43303	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	45227	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	45237	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	46628	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	46684	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	49032	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	49227	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	49524	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	49702	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	51223	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	52839	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	52871	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	53050	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	54052	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	55509	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	57304	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	57406	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	57876	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	58556	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	59177	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	59195	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	59934	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	60089	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	61188	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	61804	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	62125	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	63094	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	63301	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	63688	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	64348	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	64361	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	64821	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	65215	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	67294	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	67347	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	67358	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	68434	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	74522	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	75656	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	75784	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	78653	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	79583	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	79727	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	80108	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	80472	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	81177	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	81209	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	82086	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	82693	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	84254	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	95206	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	117479	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-	119657	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	16987	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	92964	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	94744	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	115451	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	118825	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	126173	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	128239	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	129283	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	132551	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	135730	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	135971	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	137422	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	139381	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	139623	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	146541	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	147415	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	147747	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	156065	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	159091	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	160285	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	163421	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	163461	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	165004	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	167895	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	173019	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	175655	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	179243	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	181239	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	183620	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	184041	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	186565	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	186855	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	188316	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	191946	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	193645	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	195795	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	198534	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	199473	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	199720	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	200818	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	213805	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	215157	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	215391	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	217640	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	221540	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	226660	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	228065	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	229746	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	230999	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	234032	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	236017	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	237698	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	238658	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	238767	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	239705	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	240230	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	242063	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	242227	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	243849	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	243994	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	246964	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	250767	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	253608	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	256281	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	257180	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	267114	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	268896	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	279666	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	282111	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	283592	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	284512	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	285257	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	286146	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	288768	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	293722	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	297731	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	305155	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	308058	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	312484	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	315107	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	319594	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	329270	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	334317	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	336431	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	338197	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	340396	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	357792	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	362250	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	364330	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	372816	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	387875	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	429872	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	480485	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	542335	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	574107	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	591143	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	5-OXOPROLINE (CAS# 4042-36-8); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	N	N

Return to search page